Alexander Street
Abyssinia Expeditionary Force IOR/L/MIL/5/609
0000 - Gale Group | NCCO EuropeAfrica
Vassiliki Aleporou‐Marinou, Nausica Sakarelou‐Papapetrou, Aris Antsaklis, Phaedon Fessas, Dimitris Loukopoulos,
... Athens School of Medicine “Vassilevs Pavlos” Hospital Athens 609, GreeceSearch for more papers by this authorNausica Sakarelou- ... Athens School of Medicine “Vassilevs Pavlos” Hospital Athens 609, GreeceSearch for more papers by this authorAris Antsaklis, ... Athens School of Medicine “Vassilevs Pavlos” Hospital Athens 609, GreeceSearch for more papers by this authorPhaedon Fessas, ... Athens School of Medicine “Vassilevs Pavlos” Hospital Athens 609, GreeceSearch for more papers by this authorDimitris Loukopoulos, ...
Tópico(s): Hemoglobinopathies and Related Disorders
1980 - Wiley | Annals of the New York Academy of Sciences
Abyssinia Expeditionary Force IOR/L/MIL/5/609 Report. From W. P. Pactecore.
0000 - Gale Group | NCCO EuropeAfrica
Harold L. Lazar, Praveen Kerala Varma, Oz M. Shapira, Jorge A. Soto, Palma M. Shaw,
... thoracic aortic disease.J Vasc Surg. 2006; 43: 609-612Abstract Full Text Full Text PDF PubMed Scopus ( ... thoracic aortic disease.J Vasc Surg. 2006; 43: 609-612Abstract Full Text Full Text PDF PubMed Scopus ( ... thoracic aortic disease.J Vasc Surg. 2006; 43: 609-612Abstract Full Text Full Text PDF PubMed Scopus ( ... thoracic aortic disease.J Vasc Surg. 2006; 43: 609-612Abstract Full Text Full Text PDF PubMed Scopus ( ... thoracic aortic disease.J Vasc Surg. 2006; 43: 609-612Abstract Full Text Full Text PDF PubMed Scopus ( ...
Tópico(s): Trauma Management and Diagnosis
2009 - Elsevier BV | The Annals of Thoracic Surgery
Abyssinia Expeditionary Force IOR/L/MIL/5/609 Report. From S. H. Browns.
0000 - Gale Group | NCCO EuropeAfrica
Kalanethee Paul-Pletzer, Takeshi Yamamoto, Manjunatha B. Bhat, Jianjie Ma, Noriaki Ikemoto, Leslie S. Jimenez, Hiromi Morimoto, Philip G. Williams, Jerome Parness,
... amino acid sequence corresponding to RyR1 residues 590–609, were specifically labeled by [3H]azidodantrolene. A monoclonal ... are equivalent and composed of amino acids 590–609. Dantrolene is a drug that suppresses intracellular Ca2+ ... amino acid sequence corresponding to RyR1 residues 590–609, were specifically labeled by [3H]azidodantrolene. A monoclonal ... are equivalent and composed of amino acids 590–609. Dantrolene is a hydantoin derivative used to treat ... core sequence corresponding to amino acid residues 590–609 on RyR1-DP1 (amino acids 590–609) and ...
Tópico(s): Neurobiology and Insect Physiology Research
2002 - Elsevier BV | Journal of Biological Chemistry
Abyssinia Expeditionary Force IOR/L/MIL/5/609
0000 - Gale Group | NCCO EuropeAfrica
Hiroshi Tokumitsu, Hiroyuki Inuzuka, Yumi Ishikawa, Masahiko Ikeda, Ikutaro Saji, Ryōji Kobayashi,
STO-609, a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK) was synthesized, and its inhibitory ... investigated both in vitro and in vivo. STO-609 inhibits the activities of recombinant CaM-KKα and ... compound against various protein kinases revealed that STO-609 is highly selective for CaM-KK without any ... against CaM-KII is ∼10 μg/ml. STO-609 inhibits constitutively active CaM-KKα (glutathione S-transferase ( ... inhibitor of ATP. In transfected HeLa cells, STO-609 suppresses the Ca2+-induced activation of CaM-KIV ...
Tópico(s): Drug Transport and Resistance Mechanisms
2002 - Elsevier BV | Journal of Biological Chemistry
Abyssinia Expeditionary Force IOR/L/MIL/5/609 Report. From A. Semessier.
0000 - Gale Group | NCCO EuropeAfrica
Andrey A. Sharov, Lorin Weiner, Tatyana Sharova, Frank Siebenhaar, Ruzanna Atoyan, Anthony M. Reginato, Coleen A. McNamara, Keiko Funa, Barbara A. Gilchrest, Janice L. Brissette, Vladimir A. Botchkarev,
... Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA, 02118 USA Search for ... Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA, 02118 USA Search for ... Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA, 02118 USA Search for ... Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA, 02118 USA Search for ... Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA, 02118 USA Search for ...
Tópico(s): melanin and skin pigmentation
2003 - Springer Nature | The EMBO Journal
IEEE Xplore
Abyssinia Expeditionary Force IOR/L/MIL/5/609
0000 - Gale Group | NCCO EuropeAfrica
Hiroshi Tokumitsu, Hiroyuki Inuzuka, Yumi Ishikawa, Ryōji Kobayashi,
We recently developed STO-609, a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK), and we demonstrated that CaM-KKβ is more sensitive to STO-609 than the CaM-KKα isoform (Tokumitsu H., Inuzuka ... confers a distinct sensitivity (∼10-fold) to STO-609 on CaM-KK isoforms. Various mutations of Val269 ... KIV activation in transfected HeLa cells by STO-609 treatment was completely abolished by the co-expression ... distinct sensitivity of CaM-KK isoforms to STO-609 is because of a single amino acid substitution ( ...
Tópico(s): Melanoma and MAPK Pathways
2003 - Elsevier BV | Journal of Biological Chemistry
Abyssinia Expeditionary Force IOR/L/MIL/5/609 Report. From M. P. Partaere.
0000 - Gale Group | NCCO EuropeAfrica
Patricia Monteiro, David Gilot, Sophie Langouët, Olivier Fardel,
... calmodulin-dependent protein kinase kinase (CaMKK) inhibitor STO-609 (7-oxo-7 H -benzimidazo[2,1- a ] ... shown to contribute to the AhR cascade. STO-609 failed to alter up-regulation of the AhR ... p -dioxin (TCDD) in MCF-7 cells. STO-609, used at a 25 μM concentration known to ... other AhR target genes in human macrophages. STO-609-related CYP1A1 induction was prevented by chemical inhibition ... RNA-mediated knockdown expression of AhR. Moreover, STO-609 was demonstrated to physically interact with the ligand- ... nucleus. As already reported for AhR agonists, STO-609 triggered the increase of [Ca 2+ ] i and ...
Tópico(s): Drug Transport and Resistance Mechanisms
2008 - American Society for Pharmacology and Experimental Therapeutics | Drug Metabolism and Disposition
Abyssinia Expeditionary Force IOR/L/MIL/5/609
0000 - Gale Group | NCCO EuropeAfrica
Sinoj Abraham, Yun Hwan Park, Jin Kyu Lee, Chang‐Sik Ha, Il Kim,
... Pusan National University, Jangjeon-dong, Geumjeong-gu Busan, 609-735 (Korea) Current address: Lipid Utilization Research Program, ... Pusan National University, Jangjeon-dong, Geumjeong-gu Busan, 609-735 (Korea)Search for more papers by this ... Pusan National University, Jangjeon-dong, Geumjeong-gu Busan, 609-735 (Korea)Search for more papers by this ... Pusan National University, Jangjeon-dong, Geumjeong-gu Busan, 609-735 (Korea)Search for more papers by this ... Pusan National University, Jangjeon-dong, Geumjeong-gu Busan, 609-735 (Korea)Department of Polymer Science and Engineering ...
Tópico(s): Advanced Polymer Synthesis and Characterization
2008 - | Advanced Materials
Abyssinia Expeditionary Force IOR/L/MIL/5/609 Report. From W. Girffith.
0000 - Gale Group | NCCO EuropeAfrica
Christopher Hull, Johan Harmenberg, Eva Arlander, Fred Y. Aoki, Johan Bring, Börje Darpö, Myron J. Levin, Stephen K. Tyring, Spotswood L. Spruance,
... topical corticosteroids for herpes simplex labialis (HSL). ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir ... were randomized to self-initiate treatment with ME-609, 5% acyclovir in ME-609 vehicle, or ME-609 vehicle (placebo) at the earliest sign of a ... experienced a recurrence and initiated treatment with ME-609 (n = 601), acyclovir (n = 610), or placebo (n = 232). Results Of patients receiving ME-609, 42% did not develop an ulcerative lesion compared with 35% of patients receiving acyclovir in ME-609 vehicle (P = .014) and 26% of patients receiving ...
Tópico(s): Urticaria and Related Conditions
2010 - Elsevier BV | Journal of the American Academy of Dermatology
Abyssinia Expeditionary Force IOR/L/MIL/5/609
0000 - Gale Group | NCCO EuropeAfrica
... Nat. Genet. 2009; 41: 776-782Crossref PubMed Scopus (609) Google ScholarCD226rs7633611.12AIMSGC, 200926International Multiple Sclerosis Genetics Consortium ( ... Nat. Genet. 2009; 41: 776-782Crossref PubMed Scopus (609) Google ScholarIRF8rs174458360.8ADe Jager et al., 200819De Jager ... Nat. Genet. 2009; 41: 776-782Crossref PubMed Scopus (609) Google ScholarTNFRSF1Ars18006931.2CDe Jager et al., 200819De Jager ... Nat. Genet. 2009; 41: 776-782Crossref PubMed Scopus (609) Google ScholarTNFRSF1Ars41495841.58TDe Jager et al., 200819De Jager ...
Tópico(s): Evolution and Genetic Dynamics
2010 - Elsevier BV | The American Journal of Human Genetics